Merit Medical Systems, Inc. (MMSI)
USD 97.13
(-1.89%)
USD 97.13
(-1.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 459.92 Million USD | -4.24% |
| 2022 | 418.03 Million USD | 2.73% |
| 2021 | 406.93 Million USD | 14.55% |
| 2020 | 355.26 Million USD | -9.58% |
| 2019 | 392.88 Million USD | 17.09% |
| 2018 | 335.55 Million USD | 19.61% |
| 2017 | 280.53 Million USD | 22.17% |
| 2016 | 229.62 Million USD | 16.47% |
| 2015 | 197.15 Million USD | 6.85% |
| 2014 | 184.52 Million USD | 13.53% |
| 2013 | 162.52 Million USD | 8.42% |
| 2012 | 149.9 Million USD | 18.56% |
| 2011 | 126.44 Million USD | 22.82% |
| 2010 | 102.95 Million USD | 35.54% |
| 2009 | 75.95 Million USD | 21.94% |
| 2008 | 62.28 Million USD | 9.62% |
| 2007 | 56.82 Million USD | 5.09% |
| 2006 | 54.06 Million USD | 18.65% |
| 2005 | 45.57 Million USD | 13.5% |
| 2004 | 40.15 Million USD | 14.41% |
| 2003 | 35.09 Million USD | 10.57% |
| 2002 | 31.73 Million USD | 12.72% |
| 2001 | 28.15 Million USD | -10.56% |
| 2000 | 31.48 Million USD | 14.07% |
| 1999 | 27.6 Million USD | 17.45% |
| 1998 | 23.5 Million USD | 3.07% |
| 1997 | 22.8 Million USD | 18.75% |
| 1996 | 19.2 Million USD | 14.29% |
| 1995 | 16.8 Million USD | 20.86% |
| 1994 | 13.9 Million USD | 32.38% |
| 1993 | 10.5 Million USD | 15.38% |
| 1992 | 9.1 Million USD | 75.0% |
| 1991 | 5.2 Million USD | 126.09% |
| 1990 | 2.3 Million USD | 2200.0% |
| 1989 | 100 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 120.17 Million USD | 4.72% |
| 2024 Q2 | 114.84 Million USD | -0.92% |
| 2024 Q1 | 115.91 Million USD | 13.14% |
| 2023 Q2 | 121.05 Million USD | 8.61% |
| 2023 Q3 | 106.5 Million USD | -12.02% |
| 2023 Q4 | 102.44 Million USD | -3.81% |
| 2023 FY | 400.3 Million USD | -4.24% |
| 2023 Q1 | 111.45 Million USD | 7.5% |
| 2022 Q4 | 103.67 Million USD | -4.88% |
| 2022 Q3 | 109 Million USD | 4.86% |
| 2022 Q2 | 103.95 Million USD | 2.52% |
| 2022 FY | 418.03 Million USD | 2.73% |
| 2022 Q1 | 101.4 Million USD | 4.5% |
| 2021 Q2 | 109.15 Million USD | 12.19% |
| 2021 Q3 | 103.44 Million USD | -5.23% |
| 2021 Q4 | 97.03 Million USD | -6.2% |
| 2021 FY | 406.93 Million USD | 14.55% |
| 2021 Q1 | 97.29 Million USD | 2.35% |
| 2020 Q1 | 93.68 Million USD | -4.74% |
| 2020 Q3 | 85.72 Million USD | 6.1% |
| 2020 Q4 | 95.06 Million USD | 10.9% |
| 2020 FY | 355.26 Million USD | -9.58% |
| 2020 Q2 | 80.79 Million USD | -13.76% |
| 2019 Q2 | 96.3 Million USD | 2.12% |
| 2019 Q3 | 103.92 Million USD | 7.91% |
| 2019 Q4 | 98.34 Million USD | -5.37% |
| 2019 FY | 392.88 Million USD | 17.09% |
| 2019 Q1 | 94.31 Million USD | 3.64% |
| 2018 FY | 335.55 Million USD | 19.61% |
| 2018 Q2 | 84.41 Million USD | 6.53% |
| 2018 Q4 | 90.99 Million USD | 12.47% |
| 2018 Q1 | 79.23 Million USD | 10.1% |
| 2018 Q3 | 80.9 Million USD | -4.15% |
| 2017 Q3 | 67.55 Million USD | -4.48% |
| 2017 FY | 280.53 Million USD | 22.17% |
| 2017 Q4 | 71.96 Million USD | 6.53% |
| 2017 Q2 | 70.72 Million USD | 0.61% |
| 2017 Q1 | 70.29 Million USD | 21.98% |
| 2016 Q4 | 57.63 Million USD | -10.82% |
| 2016 Q1 | 52.29 Million USD | -0.13% |
| 2016 Q2 | 55.18 Million USD | 5.53% |
| 2016 Q3 | 64.62 Million USD | 17.11% |
| 2016 FY | 229.62 Million USD | 16.47% |
| 2015 FY | 197.15 Million USD | 6.85% |
| 2015 Q2 | 48.52 Million USD | 4.22% |
| 2015 Q4 | 52.36 Million USD | 5.32% |
| 2015 Q1 | 46.55 Million USD | 1.8% |
| 2015 Q3 | 49.71 Million USD | 2.46% |
| 2014 Q4 | 45.73 Million USD | 1.6% |
| 2014 Q3 | 45.01 Million USD | -6.68% |
| 2014 Q2 | 48.24 Million USD | 5.9% |
| 2014 FY | 184.52 Million USD | 13.53% |
| 2014 Q1 | 45.55 Million USD | 7.28% |
| 2013 Q2 | 40.2 Million USD | -2.5% |
| 2013 FY | 162.52 Million USD | 8.42% |
| 2013 Q4 | 42.46 Million USD | 9.84% |
| 2013 Q1 | 41.23 Million USD | 0.25% |
| 2013 Q3 | 38.65 Million USD | -3.85% |
| 2012 Q3 | 35.97 Million USD | -2.24% |
| 2012 Q4 | 41.13 Million USD | 14.33% |
| 2012 Q2 | 36.8 Million USD | 2.26% |
| 2012 Q1 | 35.98 Million USD | 5.48% |
| 2012 FY | 149.9 Million USD | 18.56% |
| 2011 Q1 | 29.57 Million USD | -4.09% |
| 2011 Q3 | 31.1 Million USD | -1.67% |
| 2011 FY | 126.44 Million USD | 22.82% |
| 2011 Q2 | 31.63 Million USD | 6.97% |
| 2011 Q4 | 34.11 Million USD | 9.68% |
| 2010 FY | 102.95 Million USD | 35.54% |
| 2010 Q2 | 23.68 Million USD | 7.21% |
| 2010 Q3 | 26.34 Million USD | 11.25% |
| 2010 Q4 | 30.83 Million USD | 17.04% |
| 2010 Q1 | 22.08 Million USD | 11.59% |
| 2009 Q4 | 19.79 Million USD | -1.38% |
| 2009 FY | 75.95 Million USD | 21.94% |
| 2009 Q1 | 16.9 Million USD | 10.57% |
| 2009 Q2 | 19.18 Million USD | 13.44% |
| 2009 Q3 | 20.07 Million USD | 4.65% |
| 2008 Q2 | 15.49 Million USD | 3.37% |
| 2008 Q3 | 16.51 Million USD | 6.6% |
| 2008 Q4 | 15.29 Million USD | -7.41% |
| 2008 FY | 62.28 Million USD | 9.62% |
| 2008 Q1 | 14.98 Million USD | 2.1% |
| 2007 Q2 | 14.06 Million USD | -2.18% |
| 2007 Q4 | 14.68 Million USD | 7.18% |
| 2007 FY | 56.82 Million USD | 5.09% |
| 2007 Q1 | 14.37 Million USD | 0.76% |
| 2007 Q3 | 13.69 Million USD | -2.62% |
| 2006 Q1 | 13.31 Million USD | 16.34% |
| 2006 Q2 | 13.52 Million USD | 1.53% |
| 2006 Q3 | 12.93 Million USD | -4.35% |
| 2006 Q4 | 14.27 Million USD | 10.35% |
| 2006 FY | 54.06 Million USD | 18.65% |
| 2005 Q4 | 11.44 Million USD | -2.98% |
| 2005 Q3 | 11.79 Million USD | 6.55% |
| 2005 Q2 | 11.07 Million USD | -1.61% |
| 2005 Q1 | 11.25 Million USD | 5.31% |
| 2005 FY | 45.57 Million USD | 13.5% |
| 2004 Q2 | 10.06 Million USD | 3.51% |
| 2004 Q3 | 9.66 Million USD | -3.99% |
| 2004 Q4 | 10.68 Million USD | 10.55% |
| 2004 FY | 40.15 Million USD | 14.41% |
| 2004 Q1 | 9.72 Million USD | 7.3% |
| 2003 Q1 | 8.3 Million USD | 1.17% |
| 2003 FY | 35.09 Million USD | 10.57% |
| 2003 Q2 | 8.82 Million USD | 6.3% |
| 2003 Q4 | 9.06 Million USD | 1.94% |
| 2003 Q3 | 8.89 Million USD | 0.72% |
| 2002 Q4 | 8.2 Million USD | 3.49% |
| 2002 Q1 | 7.66 Million USD | 13.14% |
| 2002 Q2 | 7.92 Million USD | 3.4% |
| 2002 Q3 | 7.93 Million USD | 0.04% |
| 2002 FY | 31.73 Million USD | 12.72% |
| 2001 Q3 | 6.99 Million USD | -3.5% |
| 2001 Q4 | 6.77 Million USD | -3.11% |
| 2001 Q2 | 7.24 Million USD | -12.12% |
| 2001 FY | 28.15 Million USD | -10.56% |
| 2001 Q1 | 8.24 Million USD | 9.58% |
| 2000 Q3 | 7.81 Million USD | -2.63% |
| 2000 Q1 | 8.39 Million USD | 11.9% |
| 2000 Q2 | 8.02 Million USD | -4.37% |
| 2000 Q4 | 7.52 Million USD | -3.68% |
| 2000 FY | 31.48 Million USD | 14.07% |
| 1999 Q3 | 7 Million USD | 4.48% |
| 1999 Q1 | 6.4 Million USD | 6.67% |
| 1999 Q4 | 7.5 Million USD | 7.14% |
| 1999 Q2 | 6.7 Million USD | 4.69% |
| 1999 FY | 27.6 Million USD | 17.45% |
| 1998 Q3 | 5.6 Million USD | -9.68% |
| 1998 Q2 | 6.2 Million USD | 6.9% |
| 1998 Q1 | 5.8 Million USD | -3.33% |
| 1998 Q4 | 6 Million USD | 7.14% |
| 1998 FY | 23.5 Million USD | 3.07% |
| 1997 FY | 22.8 Million USD | 18.75% |
| 1997 Q1 | 5.2 Million USD | 0.0% |
| 1997 Q4 | 6 Million USD | 5.26% |
| 1997 Q3 | 5.7 Million USD | -1.72% |
| 1997 Q2 | 5.8 Million USD | 11.54% |
| 1996 Q2 | 4.8 Million USD | 4.35% |
| 1996 FY | 19.2 Million USD | 14.29% |
| 1996 Q3 | 4.5 Million USD | -6.25% |
| 1996 Q4 | 5.2 Million USD | 15.56% |
| 1996 Q1 | 4.6 Million USD | 21.05% |
| 1995 FY | 16.8 Million USD | 20.86% |
| 1995 Q4 | 3.8 Million USD | -13.64% |
| 1995 Q3 | 4.4 Million USD | 0.0% |
| 1995 Q2 | 4.4 Million USD | 10.0% |
| 1995 Q1 | 4 Million USD | -2.44% |
| 1994 Q4 | 4.1 Million USD | 20.59% |
| 1994 FY | 13.9 Million USD | 32.38% |
| 1994 Q1 | 2.9 Million USD | 3.57% |
| 1994 Q2 | 3.4 Million USD | 17.24% |
| 1994 Q3 | 3.4 Million USD | 0.0% |
| 1993 Q2 | 2.6 Million USD | 4.0% |
| 1993 FY | 10.5 Million USD | 15.38% |
| 1993 Q1 | 2.5 Million USD | 4.17% |
| 1993 Q4 | 2.8 Million USD | 7.69% |
| 1993 Q3 | 2.6 Million USD | 0.0% |
| 1992 Q2 | 2.2 Million USD | -4.35% |
| 1992 Q1 | 2.3 Million USD | 27.78% |
| 1992 Q3 | 2.2 Million USD | 0.0% |
| 1992 FY | 9.1 Million USD | 75.0% |
| 1992 Q4 | 2.4 Million USD | 9.09% |
| 1991 FY | 5.2 Million USD | 126.09% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q3 | 1.2 Million USD | 0.0% |
| 1991 Q4 | 1.8 Million USD | 50.0% |
| 1991 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | -4.3 Million USD | 0.0% |
| 1990 FY | 2.3 Million USD | 2200.0% |
| 1990 Q2 | - USD | 0.0% |
| 1989 FY | 100 Thousand USD | 0.0% |
| 1989 Q4 | -1.8 Million USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -341.093% |
| AngioDynamics, Inc. | 252.41 Million USD | -82.21% |
| AtriCure, Inc. | 327.05 Million USD | -40.628% |
| Avinger, Inc. | 18.63 Million USD | -2367.69% |
| Azenta, Inc. | 336.26 Million USD | -36.775% |
| BioLife Solutions, Inc. | 117.57 Million USD | -291.172% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 74.796% |
| Daxor Corporation | 1.28 Million USD | -35817.424% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -1801.236% |
| Femasys Inc. | 15.2 Million USD | -2925.779% |
| GlucoTrack, Inc. | 7.1 Million USD | -6374.212% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -685.115% |
| Hologic, Inc. | 1.34 Billion USD | 65.81% |
| ICU Medical, Inc. | 717.04 Million USD | 35.858% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 84.476% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -1661.645% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -409.125% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 385528.521% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 385528.521% |
| Masimo Corporation | 867 Million USD | 46.952% |
| Microbot Medical Inc. | 9.85 Million USD | -4566.951% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -2396.886% |
| Nephros, Inc. | 9.78 Million USD | -4600.818% |
| NovoCure Limited | 613.92 Million USD | 25.084% |
| NEXGEL, Inc. | 4.09 Million USD | -11128.711% |
| NEXGEL, Inc. | 4.09 Million USD | -11128.711% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -349.838% |
| OraSure Technologies, Inc. | 125.34 Million USD | -266.938% |
| Pro-Dex, Inc. | 7.37 Million USD | -6133.776% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -955.51% |
| Predictive Oncology Inc. | 15.22 Million USD | -2919.975% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -5296.879% |
| QuidelOrtho Corporation | 1.35 Billion USD | 66.064% |
| Repligen Corporation | 261.12 Million USD | -76.135% |
| Sanara MedTech Inc. | 61.12 Million USD | -652.412% |
| STAAR Surgical Company | 224.55 Million USD | -104.818% |
| Sharps Technology, Inc. | 10.12 Million USD | -4441.759% |
| Utah Medical Products, Inc. | 13.26 Million USD | -3368.275% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 74.363% |
| Jin Medical International Ltd. | 3.91 Million USD | -11640.129% |